Patents by Inventor Al-Walid Mohsen Mohamed

Al-Walid Mohsen Mohamed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of medium-chain acyl-CoA dehydrogenase deficiency
    Patent number: 9649285
    Abstract: The present invention provides for methods and compositions for treating medium chain acyl-CoA dehydrogenase deficiency. It is based, at least in part, on the discovery that phenylbutyrate can serve as a substrate for medium chain acyl-CoA dehydrogenase. In non-limiting embodiments, phenylbutyrate and/or another source of phenylacetate is administered as a chaperone treatment to patients suffering from medium chain acyl-CoA dehydrogenase deficiency.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: May 16, 2017
    Assignee: University of Pittsburgh-of the Commonwealth System of Higher Education
    Inventors: Al-Walid Mohsen Mohamed, Gerard Vockley
  • TREATMENT OF MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY
    Publication number: 20160166522
    Abstract: The present invention provides for methods and compositions for treating medium chain acyl-CoA dehydrogenase deficiency. It is based, at least in part, on the discovery that phenylbutyrate can serve as a substrate for medium chain acyl-CoA dehydrogenase. In non-limiting embodiments, phenylbutyrate and/or another source of phenylacetate is administered as a chaperone treatment to patients suffering from medium chain acyl-CoA dehydrogenase deficiency.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 16, 2016
    Applicant: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Al-Walid Mohsen Mohamed, Gerard Vockley
  • Treatment of medium-chain acyl-CoA dehydrogenase deficiency
    Patent number: 9283200
    Abstract: The present invention provides for methods and compositions for treating medium chain acyl-CoA dehydrogenase deficiency. It is based, at least in part, on the discovery that phenylbutyrate can serve as a substrate for medium chain acyl-CoA dehydrogenase. In non-limiting embodiments, phenylbutyrate and/or another source of phenylacetate is administered as a chaperone treatment to patients suffering from medium chain acyl-CoA dehydrogenase deficiency.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: March 15, 2016
    Inventors: Al-Walid Mohsen Mohamed, Gerard Vockley